| Literature DB >> 35558131 |
Yanqiao Li1, Longwen He2,3, Xiangting Lu4, Qian Du5, Shijun Yu3,6, Xin Huang1.
Abstract
Introduction: The stump site of amputees is clinically vulnerable and prone to various skin diseases. Data regarding the impact on quality of life (QoL) of amputees with amputation stump skin disease (ASSD) and risk factors of ASSD and stump fungal infection in the Shanghai area are yet unknown. Objective: This study aims to evaluate the QoL of amputees with ASSD and explore the risk factors of ASSD and stump fungal infection in the Shanghai area. Methodology: A total of 104 amputees from Shanghai Hebin Rehabilitation Hospital, Otto Bock (China) Industries Co., Ltd., Shanghai Tongji Hospital, and Shanghai Rehabilitation and Vocational Training Center for the Disabled were enrolled in this study. We collected demographic, clinical, and skin fungal examination data from these amputees from April 2015 to May 2021. Dermatology life quality index (DLQI) questionnaire was used to evaluate the QoL. The risk factors for ASSD and fungal skin infection were analyzed by the univariate analyses.Entities:
Keywords: amputation stump skin disease; amputees; fungal infection; quality of life; risk factors
Year: 2022 PMID: 35558131 PMCID: PMC9085623 DOI: 10.3389/fmicb.2022.868431
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
The dermatology life quality index questionnaire.
| Question1. Over the last week, does your skin itch, tenderness, pain, tingling? (Symptoms and feelings) |
| Question 2. Over the last week, do you feel embarrassed or inferior due to your skin condition? (Symptoms and feelings) |
| Question 3. Over the last week, how does it affect your shopping, housework, and yard arrangement because of skin problems? (Daily activity) |
| Question 4. Over the last week, how does skin problems affect you to wear clothes? (Daily activity) |
| Question 5. Over the last week, how much do skin problems affect your social or leisure life? (Leisure) |
| Question 6. Over the last week, how much do skin problems hinder your exercise? (Leisure) |
| Question 7. Over the last week, have skin problems prevented you from going to work or studying (Yes or no)? If your answer is no, how has your skin problem affected your work or study in the past week? (work or study) |
| Question 8. Over the last week, have skin problems prevented you from interacting with loved ones, close friends, or relatives? (Personal relationship) |
| Question 9. Over the last week, how much do skin problems affect your sex life? (Personal relationship) |
There are four answers to each question: “Very much” (score 3), “A lot” (score 2), “A little” (score 1), or “Not at all” (score 0). The question 7 has the choices “Yes” (score 3) or “No” (score 0). The total score ranges from 0 to 30. A score of ≤ 10 means moderate or less effect, and a score of > 10 corresponds to a severe or very severe impact on the QoL. The higher the score, the more the QoL is impaired.
Demographic and clinical characteristics of amputees and those with or without ASSD.
| Factors | All amputees | Non-ASSD | ASSD |
|
| |||
| Male | 76 (73.08) | 43 (68.25) | 33 (80.49) |
| Female | 28 (26.92) | 20 (31.75) | 8 (19.51) |
|
| |||
| Mean ± | 57.90 ± 11.92 | 57.19 ± 13.71 | 59.00 ± 8.50 |
|
| |||
| Mean ± | 17.73 ± 15.11 | 18.19 ± 14.91 | 17.00 ± 15.57 |
|
| |||
| N (missing) | 102 (2) | 62 (1) | 40 (1) |
| Traffic accidents | 36 (35.29) | 25 (40.32) | 11 (27.50) |
| Occupational injury | 27 (26.47) | 18 (29.03) | 9 (22.50) |
| Diabetes mellitus | 11 (10.78) | 5 (8.06) | 6 (15.00) |
| Vascular disease | 3 (2.94) | 0 (0.00) | 3 (7.50) |
| Malignant tumor | 14 (13.74) | 11 (17.74) | 3 (7.50) |
| Others | 11 (10.78) | 3 (4.85) | 8 (20.0) |
|
| |||
| N (missing) | 103 (1) | 62 (1) | 41 (0) |
| I | 4 (3.88) | 1 (1.61) | 3 (7.32) |
| II | 20 (19.42) | 12 (19.35) | 8 (19.51) |
| III | 47 (45.63) | 23 (37.10) | 24 (58.54) |
| IV | 32 (31.07) | 26 (40.94) | 6 (14.63) |
|
| |||
| Traditional | 6 (5.77) | 4 (6.35) | 2 (4.88) |
| Modern | 93 (89.42) | 55 (87.30) | 38 (92.68) |
| None | 5 (4.81) | 4 (6.35) | 1 (2.44) |
|
| |||
| Mean ± SD | 9.77 ± 3.06 | 10.38 ± 2.60 | 8.79 ± 3.51 |
|
| |||
| N (missing) | 100 (4) | 60 (3) | 40 (1) |
| Basically provided | 68 (68.00) | 41 (68.33) | 27 (67.50) |
| Partly provided | 30 (30.00) | 17 (28.33) | 13 (32.50) |
| not provided | 2 (2.00) | 2 (3.34) | 0 (0.00) |
FIGURE 1Distribution of DLQI score and six affected dimensions of QoL. (A) The distribution of amputees DLQI score. (B) DLQI score of six affected dimensions of QoL.
Distribution of participants with ASSD via the DLQI score according to sociodemographic and clinical data.
| Factors | Amputees with ASSD | Amputees with DLQI≤10 | Amputees | Statistics | |
|
| |||||
| All | 41 (0) | 38 (0) | 2 (0) | − | 1.0000 |
| Male | 33 (80.49) | 30 (78.95) | 2 (100.00) | ||
| Female | 8 (19.51) | 8 (21.05) | 0 (0.00) | ||
|
| |||||
| N (missing) | 41 (0) | 38 (0) | 2 (0) | − | 1.0000 |
| ≤60 | 24 (58.54) | 23 (60.53) | 1 (50.00) | ||
| >60 | 17 (41.46) | 15 (39.47) | 1 (50.00) | ||
|
| |||||
| N (missing) | 40 (1) | 37 (1) | 2 (0) | − | 0.5263 |
| ≤20 | 28 (70.00) | 26 (70.27) | 1 (50.00) | ||
| >20 | 12 (30.00) | 11 (29.73) | 1 (50.00) | ||
|
| |||||
| N (missing) | 41 (0) | 38 (0) | 2 (0) | χ2 = 0.13 | 0.9360 |
| Left lower limb | 18 (43.90) | 16 (42.11) | 1 (50.00) | ||
| Right lower limb | 21 (51.22) | 20 (52.63) | 1 (50.00) | ||
| Upper forearm | 2 (4.88) | 2 (5.26) | 0 (0.00) | ||
| Bilateral lower limbs | 0 (0.00) | 0 (0.00) | 0 (0.00) | ||
| Others | 0 (0.00) | 0 (0.00) | 0 (0.00) | ||
|
| |||||
| N (missing) | 41 (0) | 38 (0) | 2 (0) | χ2 = 0.27 | 0.6032 |
| I | 3 (7.32) | 3 (7.89) | 0 (0.00) | ||
| II | 8 (19.51) | 7 (18.42) | 1 (50.00) | ||
| III | 24 (58.54) | 23 (60.53) | 1 (50.00) | ||
| IV | 6 (14.63) | 5 (13.16) | 0 (0.00) | ||
|
| |||||
| N (missing) | 40 (1) | 37 (1) | 2 (0) | χ2 = 0.91 | 0.3393 |
| Basically provided | 27 (67.50) | 25 (67.57) | 2 (100.00) | ||
| Partly provided | 13 (32.50) | 12 (32.43) | 0 (0.00) | ||
|
| |||||
| N (missing) | 40 (1) | 37 (1) | 2 (0) | χ2 = 0.01 | 0.9136 |
| Primary school or below | 8 (20.00) | 8 (21.62) | 0 (0.00) | ||
| Junior high school | 21 (52.50) | 19 (51.35) | 2 (100.00) | ||
| Senior high school or technical school | 11 (27.50) | 10 (27.03) | 0 (0.00) | ||
| University and above | 0 (0.00) | 0 (0.00) | 0 (0.00) | ||
|
| |||||
| N (missing) | 41 (0) | 38 (0) | 2 (0) | χ2 = 7.07 | 0.0697 |
| Tinea corporis | 24 (58.54) | 23 (60.53) | 0 (0.00) | ||
| Intertriginous dermatitis and eczema | 5 (12.20) | 5 (13.16) | 0 (0.00) | ||
| Cutaneous keratosis | 9 (21.95) | 8 (21.05) | 1 (50.00) | ||
| Others | 3 (7.32) | 2 (5.26) | 1 (50.00) |
FIGURE 2Representative clinical lesion manifestations and patient distribution of ASSD. (A) Stump tinea corporis with fungal infection of Trichophyton rubrum (left) and Aspergillus (right). (B) Intertriginous dermatitis (left) and eczema (right). (C) Cutaneous keratosis. (D) Verrucous hyperplasia (left) and skin ulceration (right).
Predictors of risk factors for ASSD and skin fungal infection.
| Factors | Amputees | OR (95%CI) |
| ASSD with fungal infection | OR (95%CI) |
| ||
|
|
| |||||||
| Non-ASSD | ASSD | No | Yes | |||||
| Sex | 0.1730 | 0.4456 | ||||||
| Male | 43 (68.25) | 33 (80.49) | 1.92 (0.75, 4.90) | 57 (71.25) | 19 (79.17) | 1.53 (0.51, 4.59) | ||
| Female | 20 (31.75) | 8 (19.51) | 1.00 | 23 (28.75) | 5 (20.83) | 1.00 | ||
| Age (years) | 0.7112 | 0.8090 | ||||||
| ≤ 60 | 34 (54.84) | 24 (58.54) | 1.00 | 45 (56.96) | 13 (54.17) | 1.00 | ||
| >60 | 28 (45.16) | 17 (41.46) | 0.86 (0.39, 1.91) | 34 (43.04) | 11 (45.83) | 1.12 (0.45, 2.81) | ||
| Disability level | 0.0236 | 0.0187 | ||||||
| I | 1 (1.61) | 3 (7.32) | 1.00 | 2 (2.53) | 2 (8.33) | 1.00 | ||
| II | 12 (19.35) | 8 (19.51) | 0.22 (0.02, 2.53) | 18 (22.78) | 2 (8.33) | 0.11 (0.01, 1.28) | ||
| III | 23 (37.10) | 24 (58.54) | 0.35 (0.03, 3.59) | 30 (37.97) | 17 (70.83) | 0.57 (0.07, 4.39) | ||
| IV | 26 (41.94) | 6 (14.63) | 0.08 (0.01, 0.87) | 29 (36.71) | 3 (12.50) | 0.10 (0.01, 1.02) | ||
| Amputation time | 0.2913 | 0.8657 | ||||||
| ≤20 | 37 (59.68) | 28 (70.00) | 1.58 (0.68, 3.67) | 50 (63.29) | 15 (65.22) | 1.09 (0.41, 2.88) | ||
| >20 | 25 (40.32) | 12 (30.00) | 1.00 | 29 (36.71) | 8 (34.78) | 1.00 | ||
| Prosthesis wearing (daily) | 0.0395 | 0.0962 | ||||||
| ≤8 h | 9 (20.00) | 12 (42.86) | 3.00 (1.05, 8.54) | 13 (23.64) | 8 (44.44) | 2.58 (0.84, 7.91) | ||
| >8 h | 36 (80.00) | 16 (57.14) | 1.00 | 42 (76.36) | 10 (55.56) | 1.00 | ||
| Viability | 0.9446 | 0.1329 | ||||||
| Basically provided | 41 (68.33) | 27 (67.50) | 1.00 | 56 (72.73) | 12 (52.17) | 1.00 | ||
| Partly provided | 17 (28.33) | 13 (32.50) | 1.16 (0.49, 2.77) | 19 (24.68) | 11 (47.83) | 2.70 (1.02, 7.12) | ||
| Not provided | 2 (3.33) | 0 (0.00) | 2 (2.60) | 0 (0.00) | − | |||
| Prosthetic type | 0.6366 | 0.8677 | ||||||
| Traditional | 4 (6.35) | 2 (4.88) | 1.00 | 4 (5.00) | 2 (8.33) | 1.00 | ||
| Modern | 55 (87.30) | 38 (92.68) | 1.38 (0.24, 7.93) | 71 (88.75) | 22 (91.67) | 0.62 (0.11, 3.61) | ||
| None | 4 (6.35) | 1 (2.44) | 0.50 (0.03, 7.99) | 5 (6.25) | 0 (0.00) | − | ||
| Prosthesis cleaning (daily) | 0.3168 | 0.4218 | ||||||
| Yes | 48 (96.00) | 28 (90.32) | 0.39 (0.06, 2.47) | 58 (95.08) | 18 (90.00) | 0.47 (0.07, 3.01) | ||
| No | 2 (4.00) | 3 (9.68) | 1.00 | 3 (4.92) | 2 (10.00) | 1.00 | ||
| ASSD season | 0.0100 | 0.1307 | ||||||
| Spring | 23 (36.51) | 12 (29.27) | 1.00 | 30 (37.50) | 5 (20.83) | 1.00 | ||
| Summer | 11 (17.46) | 19 (46.34) | 3.31 (1.19, 9.17) | 18 (22.50) | 12 (50.00) | 4.00 (1.21, 13.22) | ||
| Autumn | 12 (19.05) | 7 (17.07) | 1.12 (0.35, 3.58) | 12 (15.00) | 7 (29.17) | 3.50 (0.93, 13.22) | ||
| Winter | 17 (26.98) | 3 (7.32) | 0.34 (0.08, 1.39) | 20 (25.00) | 0 (0.00) | − | ||
FIGURE 3Fungal species identification outcomes and the ways to skin rehabilitation guidance. (A) Fungal species identification findings from 24 amputees of fungal skin infection. (B) The methods of prosthesis nursing and skin rehabilitation guidance.